Trial Profile
A Pilot Trial of Naltrexone-Bupropion Combination Versus Placebo Combined With Bupropion for Weight Loss in Comorbid Schizophrenia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2019
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Naltrexone (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms NBC
- 05 Aug 2019 Status changed from recruiting to discontinued.
- 26 Jun 2017 Status changed from not yet recruiting to recruiting.
- 02 May 2017 New trial record